# Mirtazapine in Alzheimer-associated Weight Loss

> **NCT01505504** · — · COMPLETED · sponsor: **Brugmann University Hospital** · enrollment: 22 (actual)

## Conditions studied

- Alzheimer's Disease
- Weight Loss
- Mixed Dementia
- Dementia

## Interventions

- **DRUG:** mirtazapine

## Key facts

- **NCT ID:** NCT01505504
- **Lead sponsor:** Brugmann University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01505504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01505504, "Mirtazapine in Alzheimer-associated Weight Loss". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01505504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*